Your browser doesn't support javascript.
loading
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
Luo, Huiyan; Lu, Jin; Bai, Yuxian; Mao, Teng; Wang, Jun; Fan, Qingxia; Zhang, Yiping; Zhao, Kuaile; Chen, Zhendong; Gao, Shegan; Li, Jiancheng; Fu, Zhichao; Gu, Kangsheng; Liu, Zhihua; Wu, Lin; Zhang, Xiaodong; Feng, Jifeng; Niu, Zuoxing; Ba, Yi; Zhang, Helong; Liu, Ying; Zhang, Li; Min, Xuhong; Huang, Jing; Cheng, Ying; Wang, Dong; Shen, Yu; Yang, Qing; Zou, Jianjun; Xu, Rui-Hua.
Affiliation
  • Luo H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Lu J; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, China.
  • Bai Y; Sichuan Cancer Hospital, Chengdu, China.
  • Mao T; Harbin Medical University Cancer Hospital, Harbin, China.
  • Wang J; Shanghai Chest Hospital, Shanghai, China.
  • Fan Q; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang Y; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhao K; Zhejiang Cancer Hospital, Hangzhou, China.
  • Chen Z; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Gao S; The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Li J; The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, China.
  • Fu Z; Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Gu K; 900 Hospital of the Joint Logistics Support Force, Fuzhou, China.
  • Liu Z; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wu L; Jiangxi Provincial Cancer Hospital, Nanchang, China.
  • Zhang X; Hunan Cancer Hospital, Changsha, China.
  • Feng J; Peking University Cancer Hospital and Institute, Beijing, China.
  • Niu Z; Jiangsu Cancer Hospital, Nanjing, China.
  • Ba Y; Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
  • Zhang H; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Liu Y; The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Zhang L; Henan Cancer Hospital, Zhengzhou, China.
  • Min X; Chongqing Three Gorges Central Hospital, Chongqing, China.
  • Huang J; Anhui Chest Hospital, Hefei, China.
  • Cheng Y; Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
  • Wang D; Jilin Cancer Hospital, Changchun, China.
  • Shen Y; Army Medical Center of PLA, Chongqing, China.
  • Yang Q; Jiangsu Hengrui Pharmaceuticals Co, Ltd, Shanghai, China.
  • Zou J; Jiangsu Hengrui Pharmaceuticals Co, Ltd, Shanghai, China.
  • Xu RH; Jiangsu Hengrui Pharmaceuticals Co, Ltd, Shanghai, China.
JAMA ; 326(10): 916-925, 2021 09 14.
Article in En | MEDLINE | ID: mdl-34519801
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Esophageal Squamous Cell Carcinoma Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2021 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Esophageal Squamous Cell Carcinoma Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2021 Document type: Article Affiliation country: China Country of publication: United States